Author:
D’Aiuto Carina,Lunghi Carlotta,Guénette Line,Berbiche Djamal,Bertrand Karine,Vasiliadis Helen-Maria
Abstract
Abstract
Background
Older adults are at risk of potentially inappropriate medication use given polypharmacy, multimorbidity, and age-related changes, which contribute to the growing burden associated with opioid use. The objective of this study was to estimate the costs of health service utilization attributable to opioid use and potentially inappropriate medication use involving opioids in older adults in a public health care system.
Methods
The sample included 1201 older adults consulting in primary care, covered by the public drug plan, without a cancer diagnosis and opioid use in the year before interview. Secondary analyses were conducted using two data sources: health survey and provincial administrative data. Health system costs included inpatient and outpatient visits, physician billing, and medication costs. Unit costs were calculated using annual financial and activity reports from 2013–2014, adjusted to 2022 Canadian dollars. Opioid use and potentially inappropriate medication use involving opioids were identified over 3 years. Generalized linear models with gamma distribution were employed to model 3-year costs associated with opioid use and potentially inappropriate medication use involving opioids. A phase-based approach was implemented to provide descriptive results on the costs associated with each phase: i) no use, ii) opioid use, and iii) potentially inappropriate medication use involving opioids.
Results
Opioid use and potentially inappropriate medication use involving opioids were associated with adjusted 3-year costs of $2,222 (95% CI: $1,179-$3,264) and $8,987 (95% CI: $7,370-$10,605), respectively, compared to no use. In phase-based analyses, costs were the highest during inappropriate use.
Conclusions
Potentially inappropriate medication use involving opioids is associated with higher costs compared to those observed with opioid use and no use. There is a need for more effective use of health care resources to reduce costs for the health care system.
Funder
Health Canada and the Ministry of Health and Social Services
Fonds de recherche du Québec - Santé
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Canadian Institute for Substance Use Research (CISUR), Canadian Centre on Substance Use and Addiction (CCSA). Canadian substance use costs and harms 2015–2017. 2020. https://csuch.ca/publications/CSUCH-Canadian-Substance-Use-Costs-Harms-Report-2020-en.pdf. Accessed 3 Nov 2020.
2. Canadian Institute for Health Information (CIHI). Hospitalizations and emergency department visits due to opioid poisoning in Canada. 2016. https://secure.cihi.ca/free_products/Opioid%20Poisoning%20Report%20%20EN.pdf. Accessed 27 July 2022.
3. Kwan D, Farrell B. Polypharmacy: optimizing medication use in elderly patients. Can Geriatr Soc J CME. 2014;4(1):7.
4. Clark CM, Shaver AL, Aurelio LA, Feuerstein S, Wahler RG, Daly CJ, et al. Potentially inappropriate medications are associated with increased healthcare utilization and costs. J Am Geriatr Soc. 2020;68(11):2542–50.
5. Hyttinen V, Jyrkkä J, Valtonen H. A systematic review of the impact of potentially inappropriate medication on health care utilization and costs among older adults. Med Care. 2016;54(10):950–64.